990
Participants
Start Date
January 10, 2021
Primary Completion Date
September 15, 2026
Study Completion Date
September 15, 2026
Pembrolizumab
IV infusion
Carboplatin
IV infusion
Paclitaxel
IV infusion
Placebo for pembrolizumab
IV infusion
Docetaxel
IV infusion docetaxel 75 mg/m\^2 Q3W or 25 mg/m2 QW may be given in place of paclitaxel following sponsor consultation if a participant experiences severe hypersensitivity to paclitaxel or an adverse event requiring discontinuation of paclitaxel.
Cisplatin
Cisplatin 75 mg/m\^2 IV infusion Q3W may be given in place of carboplatin following sponsor consultation if a participant experiences severe hypersensitivity to carboplatin or an adverse event requiring discontinuation of carboplatin.
External Beam Radiotherapy (EBRT)
≥4500 cGY given according to local practice, at the discretion of the investigator
Cisplatin (as radiosensitizer)
If a participant receives external beam radiotherapy (EBRT), then cisplatin 50 mg/m\^2 IV infusion may be administered as a radiosensitizer at the discretion of the investigator, on days 1 and 29
Brachytherapy
Given according to local practice, at the discretion of the investigator
Linkou Chang Gung Memorial Hospital ( Site 4091), Taoyuan District
Saint-Luc UCL ( Site 2042), Brussels
Rigshospitalet University Hospital ( Site 2515), Copehagen
Herlev Hospital ( Site 2514), Herlev
UZ Leuven ( Site 2040), Leuven
CHC - Groupe Sante ( Site 2041), Liège
CHU Liege Sart-Tilman ( Site 2044), Liège
Roskilde Sygehus ( Site 2513), Roskilde
Soerlandet sykehus HF Kristiansand ( Site 2152), Kristiansand
CHR Verviers ( Site 2035), Verviers
Odense Universitetshospital ( Site 2512), Odense
Medizinische Universitaet Innsbruck ( Site 2001), Innsbruck
C.I.U. Hopital Ambroise Pare ( Site 2039), Mons
Medizinische Universitat Graz ( Site 2004), Graz
AZ Groeninge ( Site 2036), Kortrijk
AZ Maria Middelares Gent ( Site 2032), Ghent
Universitair Ziekenhuis Gent ( Site 2037), Ghent
University Hospital of North Norway ( Site 2153), Tromsø
AZ Nikolaas ( Site 2031), Sint-Niklaas
Aalborg Universitetshospital ( Site 2511), Aalborg
OLV Ziekenhuis ( Site 2038), Aalst
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 3042), New York
Istituto di Candiolo - IRCCS ( Site 2125), Candiolo
National Cancer Center ( Site 4065), Goyang-si
MacKay Memorial Hospital ( Site 4092), Taipei
Montefiore Medical Center ( Site 3065), The Bronx
Taipei Veterans General Hospital ( Site 4093), Taipei
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 3076), Mineola
Seoul National University Bundang Hospital ( Site 4063), Seongnam-si
Hospital Universitario Reina Sofia ( Site 2183), Córdoba
Chernihiv Medical Center of Modern Oncology ( Site 2368), Chernihiv
Centre Francois Baclesse ( Site 2062), Caen
Instituto Nacional de Cancerologia ( Site 1124), Mexico City
AHN West Penn Hospital ( Site 3060), Pittsburgh
Hospital Josep Trueta ( Site 2184), Girona
Abington Hospital - Asplundh Cancer Center ( Site 3073), Willow Grove
Sidney Kimmel Cancer Center - Jefferson Health ( Site 3078), Philadelphia
IRCCS Ospedale San Raffaele ( Site 2130), Milan
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 2122), Milan
Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 2132), Milan
Turku University Hospital ( Site 2542), Turku
Hôpital Privé Des Côtes d'Armor ( Site 2063), Plérin
Investigacion Onco Farmaceutica S de RL de CV ( Site 1127), La Paz
VCU Massey Cancer Center ( Site 3068), Richmond
Universitätsklinikum Schleswig-Holstein ( Site 2101), Lübeck
CHU Besancon - Hopital Jean Minjoz ( Site 2068), Besançon
Azienda Ospedaliera Spedali Civili di Brescia ( Site 2135), Brescia
Duke Cancer Center ( Site 3072), Durham
Clinica Universitaria de Navarra ( Site 2181), Madrid
Hospital Clinico San Carlos ( Site 2187), Madrid
Hospital Universitario La Paz ( Site 2186), Madrid
"MNE Khmelnytskyi regional antitumor center ( Site 2365)", Khmelnitskyi
Hospital San Lucas Cardiologica del Sureste ( Site 1122), Tuxtla Gutiérrez
Northside Hospital ( Site 3036), Atlanta
Medizinische Hochschule Hannover-Department of Obstetrics and Gynecology ( Site 2109), Hanover
Institut Universitaire du Cancer Toulouse - Oncopole ( Site 2065), Toulouse
Institut Bergonie ( Site 2067), Bordeaux
Mount Sinai Cancer Center ( Site 3081), Miami Beach
Tampere University Hospital ( Site 2541), Tampere
Medipol Universite Hastanesi ( Site 2352), Istanbul
Institut Regional du Cancer de Montpellier - ICM ( Site 2069), Montpellier
Ege University Medical Faculty ( Site 2351), Izmir
Istituto Oncologico Veneto IRCCS-Oncologia 2 ( Site 2134), Padua
University of Alabama - Birmingham ( Site 3061), Birmingham
I.E.U. Medical Point Hastanesi ( Site 2356), Izmir
University of South Alabama, Mitchell Cancer Institute ( Site 3058), Mobile
Norton Cancer Institute - St. Matthews ( Site 3056), Louisville
Taichung Veterans General Hospital ( Site 4094), Taichung
The Municipal Enterprise Volyn Regional Medical Oncology Centre ( Site 2362), Lutsk
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2482), Gliwice
Hopital prive du Confluent ( Site 2061), Nantes
Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung ( Site 2105), Essen
Indiana University Melvin and Bren Simon Cancer Center ( Site 3071), Indianapolis
Parkview Cancer Institute ( Site 3067), Fort Wayne
Changhua Christian Hospital ( Site 4095), Changhua
University of Iowa Hospital and Clinics ( Site 3046), Iowa City
Universitätsklinikum Bonn-Gynaecological oncology ( Site 2103), Bonn
Institut De Cancerologie De Lorraine ( Site 2072), Vandœuvre-lès-Nancy
Sanford Gynecology Oncology ( Site 3045), Sioux Falls
"Municipal Enterprise Bukovinian сlinical oncology сenter ( Site 2366)", Chernivtsi
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 3080), Fargo
Northwestern Memorial Hospital ( Site 3044), Chicago
SO Grigoriev Institute for Medical Radiology and Oncology of NAMS of Ukraine ( Site 2363), Kharkiv
Fakultní nemocnice Brno Bohunice-Gynekologicko-porodnicka klinika ( Site 2394), Brno
Christus Muguerza Clinica Vidriera ( Site 1125), Monterrey
I Can Oncology Center SA de CV ( Site 1126), Monterrey
Centre Hospitalier Lyon Sud ( Site 2064), Pierre-Bénite
Kuopio University Hospital ( Site 2543), Kuopio
WK Physicians Network/Gynecologic Oncology Associates ( Site 3047), Shreveport
Klinikum Ludwigsburg ( Site 2111), Ludwigsburg
Universitaetsklinikum Tuebingen ( Site 2113), Tübingen
SLK-Kliniken Heilbronn GmbH ( Site 2116), Heilbronn
Hopital Cochin ( Site 2070), Paris
UT Southwestern Medical Center ( Site 3063), Dallas
Lviv State Regional Oncological Center ( Site 2361), Lviv
University Of Colorado ( Site 3051), Aurora
Azienda Ospedaliera Universitaria Federico II ( Site 2123), Napoli
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 2127), Napoli
HonorHealth Research Institute - Biltmore ( Site 3043), Phoenix
Arizona Oncology Associates PC- HOPE ( Site 3049), Tucson
Gustave Roussy ( Site 2071), Villejuif
Legacy Good Samaritan Medical Center ( Site 3033), Portland
Beijing Cancer Hospital ( Site 4048), Beijing
Peking Union Medical College Hospital ( Site 4036), Beijing
Instituto Nacional de Cancerología E.S.E ( Site 1094), Bogotá
FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 2634), Moscow
Moscow Research Oncology Institute named after P.A. Hertsen ( Site 2631), Moscow
The First Bethune Hospital of Jilin University ( Site 4057), Changchun
Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 2641), Yaroslavl
Harbin Medical University Cancer Hospital ( Site 4033), Harbin
Arkhangelsk Clinical Oncological Dispensary ( Site 2637), Arkhangelsk
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 2636), Saint Petersburg
Obstetrics and Gynecology Hosp. Fudan University ( Site 4041), Shanghai
Shanghai Renji Hospital Affiliated to Jiao Tong University ( Site 4053), Shanghai
Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 4001), Shanghai
Nanjing Drum Tower Hospital ( Site 4037), Nanjing
Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 4034), Hefei
Tianjin Medical University Cancer Institute & Hospital ( Site 4054), Tianjin
The First Affiliated Hospital, Zhejiang University-Gynecology ( Site 4002), Hangzhou
Women s Hospital School of Medicine Zhejiang University ( Site 4032), Hangzhou
The First Affiliated Hospital of Wenzhou Medical University ( Site 4056), Wenzhou
The First Affiliated Hospital of Xiamen University ( Site 4060), Xiamen
Chongqing Cancer Hospital ( Site 4040), Chongqing
Xiangya Hospital Central-South University ( Site 4035), Changsha
Hunan Cancer Hospital ( Site 4050), Changsha
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2646), Kazan'
National Research Ogarev Mordovia State University ( Site 2648), Saransk
Hubei Cancer Hospital ( Site 4059), Wuhan
Samara Regional Clinical Oncology Center-Chemotherapy Dapartment ( Site 2649), Samara
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 2645), Ufa
Chelyabinsk Regional Clinical Center Oncology and Nuclear Medicine ( Site 2644), Chelyabinsk
The First Affiliated Hospital ( Site 4043), Guangzhou
Instituto Cancerologico de Narino Ltda ( Site 1092), Pasto
Guangxi Medical University Affiliated Tumor Hospital ( Site 4049), Nanning
Jiangxi Maternal and Child Health Hospital ( Site 4051), Nanchang
Nizhegorodsky Regional Oncology Dispensary-chemotherapy department (Branch№1) ( Site 2639), Nizhny Novgorod
Sichuan Cancer Hospital ( Site 4039), Chengdu
Tomsk Scientific Research Institute of Oncology-Chemotherapy ( Site 2638), Tomsk
Yunnan Province Cancer Hospital-Gynecology Department ( Site 4055), Kunming
Krasnoyarsk Regional Clinical oncology dispensary ( Site 2643), Krasnoyarsk
The First Affiliated Hospital of Xi an Jiaotong University ( Site 4045), Xi'an
Fundacion Valle del Lili ( Site 1093), Santiago de Cali
Rambam Medical Center ( Site 2307), Haifa
Centro Investigación del Cáncer James Lind ( Site 1061), Temuco
Rabin Medical Center ( Site 2305), Petah Tikva
Chaim Sheba Medical Center ( Site 2301), Ramat Gan
Edith Wolfson Medical Center ( Site 2306), Holon
Fundacion Arturo Lopez Perez FALP ( Site 1062), Santiago
Ehime University Hospital ( Site 4187), Tōon
Centro de Cancer Nuestra Senora de la Esperanza ( Site 1063), Santiago
Bradfordhill-Clinical Area ( Site 1070), Santiago
Hadassah Medical Center. Ein Kerem ( Site 2303), Jerusalem
UCSD Moores Cancer Center ( Site 3053), La Jolla
Smilow Cancer Hospital at Yale New Haven ( Site 3070), New Haven
University of Massachusetts Medical School ( Site 3037), Worcester
Centro de Oncología e Investigación de Buenos Aires ( Site 1005), Berazategui
IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 1006), Caba
IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 1010), Buenos Aires
Instituto de Investigaciones Clinicas Mar del Plata ( Site 1003), Mar del Plata
Hospital Britanico de Buenos Aires ( Site 1002), Buenos Aires
Instituto de Oncologia de Rosario ( Site 1004), Rosario
Hospital Aleman ( Site 1001), Buenos Aires
CEMIC ( Site 1009), Buenos Aires
Centro Oncologico Riojano Integral ( Site 1007), La Rioja
Tom Baker Cancer Centre ( Site 3007), Calgary
Kingston Health Sciences Centre ( Site 3003), Kingston
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 3006), Montreal
McGill University Health Centre ( Site 3005), Montreal
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 3, Québec
Oncocentro ( Site 1065), Viña del Mar
Leicester Royal Infirmary. Univ. Hosp. of Leicester NHS Trust ( Site 2249), Leicester
Clínica Vida Fundación - Sede Poblado ( Site 1096), Medellín
Fakultni nemocnice Kralovske Vinohrady ( Site 2393), Prague
Vseobecna fakultni nemocnice v Praze ( Site 2391), Prague
Fakultni nemocnice Olomouc ( Site 2392), Olomouc
Centre Antoine Lacassagne ( Site 2073), Nice
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden
General Hospital of Patras. St Andrews ( Site 2421), Pátrai
Geniko Panepistimako Nosokomeio ARETEIO ( Site 2423), Athens
Perifereiako Geniko Nosokomeio ALEXANDRA ( Site 2425), Athens
Athens University Hospital ATTIKON ( Site 2424), Chaïdári
Hospital Hygeia ( Site 2426), Marousi
Euromedica General Clinic of Thessaloniki ( Site 2422), Thessaloniki
Istittuto Nazionale dei Tumori Regina Elena IRCCS - IFO ( Site 2121), Roma
Fondazione Policlinico Universitario Agostino Gemelli ( Site 2124), Rome
Aichi Cancer Center Hospital ( Site 4190), Nagoya
National Cancer Center Hospital East ( Site 4197), Kashiwa
National Hospital Organization Shikoku Cancer Center ( Site 4181), Matsuyama
Kurume University Hospital ( Site 4186), Kurume
Gunma Prefectural Cancer Center ( Site 4183), Ōta
Hokkaido University Hospital ( Site 4194), Sapporo
Hyogo Cancer Center ( Site 4195), Akashi
Iwate Medical University Hospital ( Site 4189), Shiwa-gun
University of the Ryukyus Hospital ( Site 4184), Nakagami-gun
Saitama Medical University International Medical Center ( Site 4182), Hidaka
Shizuoka Cancer Center Hospital and Research Institute ( Site 4192), Sunto-gun
National Hospital Organization Kyushu Cancer Center ( Site 4193), Fukuoka
Niigata Cancer Center Hospital ( Site 4185), Niigata
Osaka International Cancer Institute ( Site 4188), Osaka
The Cancer Institute Hospital of JFCR ( Site 4196), Tokyo
Keio University Hospital ( Site 4191), Tokyo
Centro Oncologico Internacional. SEDNA ( Site 1121), Mexico City
Hospital Angeles Roma ( Site 1123), Mexico City
Oslo Universitetssykehus Radiumhospitalet ( Site 2151), Oslo
Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 2484), Poznan
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2487), Siedlce
Szpital Kliniczny im Ks Anny Mazowieckiej ( Site 2481), Warsaw
Bialostockie Centrum Onkologii ( Site 2483), Bialystok
SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2486), Olsztyn
Swietokrzyskie Centrum Onkologii SPZOZ ( Site 2485), Kielce
Severance Hospital Yonsei University Health System ( Site 4062), Seoul
Asan Medical Center ( Site 4061), Seoul
Samsung Medical Center ( Site 4064), Seoul
Hospital Vall D Hebron ( Site 2182), Barcelona
Hospital Clinic i Provincial ( Site 2185), Barcelona
Karolinska Universitetssjukhuset Solna ( Site 2220), Solna
Blod-och Tumorsjukdomar ( Site 2221), Uppsala
Universitetssjukhuset i Linkoping. ( Site 2222), Linköping
Baskent Adana Dr Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 2355), Adana
Cukurova Uni. Tip Fakultesi ( Site 2353), Adana
Baskent Universitesi Ankara Hastanesi ( Site 2354), Ankara
Ankara Universitesi Tıp Fakultesi Hastanesi ( Site 2350), Ankara
LISOD - Israeli Oncological Hospital MedX-ray International Group, LLC ( Site 2364), Kiev
Bristol Haematology and Oncology Centre ( Site 2244), Bristol
Castle Hill Hospital-Academic Oncology ( Site 2252), Cottingham
Beatson West of Scotland Cancer Centre ( Site 2247), Glasgow
UCLH NHS Foundation Trust ( Site 2242), London
Royal Marsden NHS Foundation Trust ( Site 2248), London
Royal Marsden Hospital Sutton-Surrey ( Site 2241), Sutton
The Christie Hospital NHS Foundation Trust ( Site 2243), Manchester
European Network for Gynaecological Oncological Trial Groups
UNKNOWN
Gynecologic Oncology Group
NETWORK
Merck Sharp & Dohme LLC
INDUSTRY